controversias: tavi - dr. lino patricio
DESCRIPTION
Presentación "Estenosis aórtica riesgo moderado" del Lino Patricio durante la Mesa Redonda Hispano-Lusa sobre Controversias de la XXV Reunión Anual de la Sección de Hemodinámica y Cardiología Intervencionista (SHCI) de 2014 en Córdoba.TRANSCRIPT
![Page 1: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/1.jpg)
ControversiaEstenosis aórtica riesgo moderado
Intermediate risk aortic StenosisTAVI
Lino Patricio, MD,PhDH.S.Marta Lisbon
H.S.E.S. ÉvoraPortugal
![Page 2: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/2.jpg)
Coronary TreatmentRecent Cardiology History
1970/
1980
1990/
2000
2000/
2005
2005/2008
2008 20102010/2015
CASS/VACABG
SVGFailure
BMS/ISRLIMA
ARTS-II/CABGPCI/CABG
ARTSERACI-II
SoSMASS-II
PCI/CABG
DESNo ISR No DM
LIMA/ECC
SYNTAX
FAME
TAXUSSYNTAXScore
FFR-PCI
COURAGECarminzid
OMTSAT
FAME-2
DES-2;3 GSyntax
Funtional
Intervention enthusiasm
FREEDOM
OCTIVUS
Surgery Enthusiasm
![Page 3: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/3.jpg)
ITT population
P=0.048
8.8%0
Months Since Allocation
Cum
ula
tive E
vent
Rate
(%
)
TAXUS (N=903)CABG (N=897)
Coronary TreatmentAll-Cause Death to 4 Years
25
50
Before 1 year*
3.5% vs 4.4%P=0.37
1-2 years*
1.5% vs 1.9%P=0.53
2-3 years*
1.9% vs 2.6%P=0.32
3-4 years*
2.2% vs 3.2%P=0.22
11.7%
0 12 4824 36
Cumulative KM Event Rate ± 1.5 SE; log-rank P value;*Binary rates
![Page 4: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/4.jpg)
Aortic Valve TreatmentRecent Cardiology History
1970/
1980
1990/
2000
2000/
2005
2005/2008
2008 20102010/2015
Intervention enthusiasmSurgery Enthusiasm
Valve Prosthesis
Balloon Valvuloplasty
TAVI
Aortic Repair
![Page 5: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/5.jpg)
0
100
200
300
400
500
600
700
800
900
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
TAVI number of publications
Pubmed
![Page 6: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/6.jpg)
Publications / week
0
5
10
15
20
25
30
TAVI CTO Mitral
![Page 7: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/7.jpg)
![Page 8: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/8.jpg)
AHA/ACC Valvular Heart Disease Guidelines
170Leon M.B., Smith C.R., Mack M., et al; Transcatheter aortic-valveimplantation for aortic stenosis in patients who cannot undergosurgery. N Engl J Med. 2010;363:1597-1607.
171Makkar R.R., Fontana G.P., Jilaihawi H., et al; Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696-1704
172Smith C.R., Leon M.B., Mack M.J., et al; Transcatheter versus surgicalaortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198.
173Murphy E.S., Lawson R.M., Starr A., et al; Severe aortic stenosisin patients 60 years of age or older: left ventricular function and 10–yearsurvival after valve replacement. Circulation. 1981;64:II184-II188.
![Page 9: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/9.jpg)
Aortic stenosisHigh Risk patients
![Page 10: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/10.jpg)
![Page 11: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/11.jpg)
CoreValve US Pivotal Trial
![Page 12: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/12.jpg)
12
![Page 13: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/13.jpg)
13
CoreValve US Pivotal Trial
![Page 14: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/14.jpg)
CoreValve US Pivotal Trial
![Page 15: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/15.jpg)
CoreValve US Pivotal Trial
![Page 16: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/16.jpg)
CoreValve US Pivotal Trial
![Page 17: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/17.jpg)
CoreValve US Pivotal Trial
![Page 18: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/18.jpg)
CoreValve US Pivotal Trial
![Page 19: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/19.jpg)
CoreValve US Pivotal Trial
![Page 20: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/20.jpg)
CoreValve US Pivotal Trial
![Page 21: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/21.jpg)
SAVRTAVR
CoreValve US Pivotal TrialProcedural Outcomes
![Page 22: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/22.jpg)
SAVRTAVR
CoreValve US Pivotal TrialAortic Gradient
Aortic Regurgitation
![Page 23: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/23.jpg)
Results
Hemodynamic Assessment of Percutaneous Versus Surgical Bioprostheses for Aortic Stenosis During Exercise: A Pilot Study
P=0,0019 para repouso e p= 0,01 para pico de esforçoP=0,003 para repouso e p= 0,004 para pico de esforço
Prostheses Aortic GradientDuring Exercise
![Page 24: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/24.jpg)
Intermediate risk aortic Stenosis
![Page 25: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/25.jpg)
![Page 26: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/26.jpg)
![Page 27: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/27.jpg)
![Page 28: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/28.jpg)
8,2
9,4
7,6 7,6 7,5
6,9
6
5,3
9,7
8,05
7,15
6,1
5,35,5
5
0
1
2
3
4
5
6
7
8
9
10
2006 2007 2008 2009 2010 2011 2012 2013
Vancouver Quebec
Evolution of STS in Vancouver and Quebec
Mediana STS
![Page 29: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/29.jpg)
417 P
Intra Hospital MortalityQuebec
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2007-08 2009 2010 2011 2012 2013
vivos Muertos
15% 19% 8.5%4% 6% 3%
![Page 30: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/30.jpg)
Coronary TreatmentRecent Cardiology History
ICP begun with simple cases and it was not competitive with surgery - with complex cases never
was better than surgery
1970/
1980
1990/
2000
2000/
2005
2005/2008
2008 20102010/2015
CASS/VACABG
SVGFailure
BMS/ISRLIMA
ARTS-II/CABGPCI/CABG
ARTSERACI-II
SoSMASS-II
PCI/CABG
DESNo ISR No DM
LIMA/ECC
SYNTAX
FAME
TAXUSSYNTAXScore
FFR-PCI
COURAGECarminzid
OMTSAT
FAME-2
DES-2;3 GSyntax
Funtional
Intervention enthusiasm
FREEDOM
OCTIVUS
Surgery Enthusiasm
![Page 31: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/31.jpg)
Aortic Valve TreatmentRecent Cardiology History
1970/
1980
1990/
2000
2000/
2005
2005/2008
2008 20102010/2015
Intervention enthusiasm
Surgery Enthusiasm
Valve Prosthesis
Balloon Valvuloplasty
TAVI
Aortic Repair
TAVI begun with complex cases and it was competitive with surgery - with simple cases will be better than surgery
![Page 32: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/32.jpg)
Por primera vez en la historia de la intervención un tratamiento percutáneo fue mejor que la cirugía
![Page 33: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/33.jpg)
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
• Untreated Severe AS
• Asymptomatic Severe AS
• AS + CAD / previous surgery
• Bioprosthetic Valve Failure
• Patient (> 75 years old) refusal
![Page 34: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/34.jpg)
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
![Page 35: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/35.jpg)
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
![Page 36: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/36.jpg)
Resultados
Eventos Intra-hospitalares na Substituição Valvular Aórtica Percutânea Versus Cirúrgica numa Amostra Emparelhada
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart TeamPropensity score matching
![Page 37: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/37.jpg)
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
• Untreated Severe AS
• Asymptomatic Severe AS
• AS + CAD / previous surgery
• Bioprosthetic Valve Failure
• Patient (> 75 years old) refusal
![Page 38: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/38.jpg)
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
![Page 39: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/39.jpg)
Patients with an AV-Vel 5.5 m/s had an event-freesurvival of 44%, 25%, 11%, and 4% at 1, 2, 3, and 4 years, Patients with an AV-Vel between 5.0 and 5.5 m/s had a even free survival of 76%, 43%, 33%, and 17% (P<0.0001).
Rosenhek, R. et al. Circulation 2010;121:151-156
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
![Page 40: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/40.jpg)
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
• Untreated Severe AS
• Asymptomatic Severe AS
• AS + CAD / previous surgery
• Bioprosthetic Valve Failure
• Patient (> 75 years old) refusal
![Page 41: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/41.jpg)
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
![Page 42: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/42.jpg)
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
![Page 43: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/43.jpg)
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
![Page 44: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/44.jpg)
• Untreated Severe AS
• Asymptomatic Severe AS
• AS + CAD / previous surgery
• Bioprosthetic Valve Failure
• Patient (> 75 years old) refusal
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
![Page 45: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/45.jpg)
TAVI
Patient Selection
Heart Team
/ previous surgery/ previous surgery
![Page 46: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/46.jpg)
• Untreated Severe AS
• Asymptomatic Severe AS
• AS + CAD / previous surgery
• Bioprosthetic Valve Failure
• Patient (> 75 years old) refusal
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
![Page 47: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/47.jpg)
No High Risk Aortic Stenosis PatientsSelection Criteria
Heart Team
![Page 48: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/48.jpg)
Por primera vez en la historia de la medicina un tratamiento percutáneo fue mejor que la cirugía
![Page 49: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/49.jpg)
![Page 50: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/50.jpg)
Inoperable patient selection criteria Strict Perspectiveis an historical, unadjusted option
The Strict Board criteria excluded the patients morefavorable to TAVI and don’t have ethical strength toexclude patients with heavy comorbidities not suitablefor any type of intervention (TAVI or AVR)
TAVI
Patient Selection
Heart Team
![Page 51: Controversias: TAVI - Dr. Lino Patricio](https://reader034.vdocuments.co/reader034/viewer/2022052311/559714a11a28abeb548b459f/html5/thumbnails/51.jpg)
Time trends in transaortic mean gradient
Gurvitch, R. et al. Circulation 2010;122:1319-1327
Time trends in aortic valve area (mean{+/-}SD)
TAVI
Patient Selection
Heart Team